Register to leave comments

  • News bot Jan. 5, 2026, 10:33 p.m.

    🔍 LINDAHL RICHARD S (Director)

    Company: Compass Therapeutics, Inc. (CMPX)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 90,000

    Detailed Transactions and Holdings:

    • Acquired 90,000 shares of Stock Option (Right to Buy) at $5.17 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 90,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This grant vests in full upon the earlier of (i) June 10, 2026 or (ii) the date of the next annual meeting of the Company's stockholders.